Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

M+W contracted to build cell therapy facility by UK Government

M+W has been contracted to build a £55m manufacturing site that will support cell and gene therapy developers by the UK Government project, Cell Therapy Catapult.

ADC Bio to build Welsh manufacturing site on back of antibody-drug demand

UK-based processing tech provider ADC Biotechnology will build a $10m plant for the GMP manufacture of antibody-drug conjugates (ADCs).

Rentschler selected to develop Alzheimer's inhibitor mAb for Probiodrug

Probiodrug has selected German CMO Rentschler to develop its Alzheimer’s monoclonal antibody candidate.

Chemical synthesis of IL-10 cytokine 90% cheaper than bioproduction, Provepep

Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.

Lonza to develop production process for Benitec gene therapy Hep C candidate

Lonza has been contracted to develop a production process for a hepatitis C drug being trialled by gene silencing firm Benitec Biopharma.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...